-
June 20, 2013
Danish drugmaker Lundbeck has been handed a 93-million-euro fine in Europe for paying companies to delay market entry for their generic versions of the antidepressant citalopram, signalling a much tougher stance on such agreements.
-
June 20, 2013
Avoidable costs of more than $200 million are incurred each year in the US healthcare system as a result of medicines not being used responsibly by patients and healthcare professionals, according to new research from IMS.
-
June 20, 2013
Vivus has presented data on its already-approved but not-yet-marketed erectile dysfunction drug Stendra which shows that the treatment is effective for sexual activity within 15 minutes.
-
June 20, 2013
ALK-Abello has unveiled positive top-line results from the first of two Phase III trials of the Danish firm's immunotherapy tablet against house dust mite allergy
-
June 20, 2013
A new report has laid out the need for drugmakers to participate in creating clearer pathways to achieve better outcomes in the face of "changing perceptions of what offers value to health systems".
-
June 19, 2013
GlaxoSmithKline says it has received an offer for its thrombosis drugs Arixtra and Fraxiparine from South Africa's Aspen Pharmacare, which is also looking to buy the facility in France where the treatments are produced
-
June 18, 2013
AstraZeneca has confirmed that it will build a global R&D centre and new corporate headquarters at the Cambridge Biomedical Campus in the UK city
-
June 19, 2013
Royalty Pharma has finally abandoned its $8 billion bid for Elan Corp, leaving observers to wonder who will make an offer for the Irish drugmaker which put itself up for sale last week
-
June 19, 2013
Astellas Pharma is weighing up the possibility of selling its dermatology portfolio, which could be worth between $500 million and $1 billion, according to a report published by Reuters
-
June 19, 2013
As part of plans to expand its respiratory franchise, Teva Pharmaceutical Industries is to acquire the USA's MicroDose Therapeutx in a deal that could be worth $165 billion